[1]
F. Spinelli, F. Conti, R. Caporali, F. Iannone, F. Cacciapaglia, and on behalf of the Steering Committee of the Italian Society of Rheumatology, “Janus kinase inhibitors: between prescription authorization and reimbursability”, Reumatismo, vol. 75, no. 4, Dec. 2023.